1 |
Serum tumor necrosis factor alpha concentration in children with Guillain Barré syndrome: Correlation with clinical disability and IVIG therapy |
|
|
| Abdeldayem, S.M. and Awad, E.M. and Hussein, W.R. and Mousa, G.R. and Selim, A.M. |
|
| Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2010; 47(3): 519-525 |
|
| [Pubmed] [Google Scholar] |
|
2 |
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders - A review |
|
|
| Kaida, K. and Ariga, T. and Yu, R.K. |
|
| Glycobiology. 2009; 19(7): 676-692 |
|
| [Pubmed] [Google Scholar] |
|
3 |
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders - A review |
|
|
| Kaida, K., Ariga, T., Yu, R.K. |
|
| Glycobiology. 2009; 19(7): 1-2 |
|
| [Pubmed] [Google Scholar] |
|
4 |
Monoclonal antibody clearance: Impact of modulating the interaction of IgG with the neonatal Fc receptor |
|
|
| Datta-Mannan, A., Witcher, D.R., Tang, Y., Watkins, J., Wroblewski, V.J. |
|
| Journal of Biological Chemistry. 2007; 282(3): 1709-1717 |
|
| [Pubmed] [Google Scholar] |
|
5 |
Association between tumor necrosis factor alpha gene polymorphism and Guillain-Barré syndrome |
|
|
| Guo, L. and Zhang, J. and Dong, H. and Li, B. and Li, C.-Y. |
|
| Chinese Journal of Neurology. 2006; 39(4): 220-223 |
|
| [Pubmed] [Google Scholar] |
|
6 |
Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss |
|
|
| Sapir, T., Blank, M., Shoenfeld, Y. |
|
| Annals of the New York Academy of Sciences. 2005; 1051: 743-778 |
|
| [Pubmed] [Google Scholar] |
|